EGFR and non-small cell lung carcinoma: However, pooled analysis of the available data revealed that only EGFR -216G>T and variable CA repeat polymorphisms significantly affect the prognosis of TKI-treated NSCLC patients, with longer OS and PFS associated with the presence of variant -216T allele and ≤16CA repeats.